The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-((4-amino-6-(((1-(3-chlorophenyl)cyclopropyl)methyl)amino)-1,3,5-triazin-2-yl)methoxy)-5-methylphenyl)pyrrolidin-2-one ID: ALA5273852
Chembl Id: CHEMBL5273852
Max Phase: Preclinical
Molecular Formula: C25H27ClN6O2
Molecular Weight: 478.98
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(OCc2nc(N)nc(NCC3(c4cccc(Cl)c4)CC3)n2)cc(N2CCCC2=O)c1
Standard InChI: InChI=1S/C25H27ClN6O2/c1-16-10-19(32-9-3-6-22(32)33)13-20(11-16)34-14-21-29-23(27)31-24(30-21)28-15-25(7-8-25)17-4-2-5-18(26)12-17/h2,4-5,10-13H,3,6-9,14-15H2,1H3,(H3,27,28,29,30,31)
Standard InChI Key: KDQLFQWNFSVHNG-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 478.98Molecular Weight (Monoisotopic): 478.1884AlogP: 4.27#Rotatable Bonds: 8Polar Surface Area: 106.26Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.17CX LogP: 4.59CX LogD: 4.58Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -1.51
References 1. Lückmann M, Shenol A, Nissen TAD, Petersen JE, Kouvchinov D, Schwartz TW, Frimurer TM.. (2022) Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action., 13 (12.0): [PMID:36518697 ] [10.1021/acsmedchemlett.2c00160 ]